Bayer to Pay $97.5 Million to Settle Kickback Probe

Bayer will pay $97.5 million to settle U.S. government allegations that the conglomerate paid kickbacks to medical suppliers to boost sales of its diabetes products. The Justice Department said Tuesday the settlement resolves an investigation into whether Bayer bribed 11 diabetic suppliers into switching patients to its products from competitors' products. Under the settlement, Bayer also agreed to a corporate integrity agreement which requires it to review and update its employee training programs.